HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
Go back to HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review| Amgen Inc (NASDAQ: AMGN) | Delayed: 380.29 +0.51 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $379.78 | 52 Week High | $176.85 | |||
| Open | $378.51 | 52 Week Low | $133.64 | |||
| Day High | $385.60 | P/E | 57.27 | |||
| Day Low | $378.51 | EPS | $6.64 | |||
| Volume | 1,431,107 | |||||
| NOVEN PHARMACEUTIC (NASDAQ: NOVN) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $23.79 | |||
| Open | $10.12 | 52 Week Low | $13.73 | |||
| Day High | $0.09 | P/E | 0.09 | |||
| Day Low | $0.09 | EPS | $1.05 | |||
| Volume | 1,574,031 | |||||
